The Loss of Estrogen and Progesterone Receptor Gene Expression in Human Breast Cancer

Journal of Mammary Gland Biology and Neoplasia

Volumn 3, Issue 1, 1998, Pages 85-94

  Lapidus, Rena G ^a   Nass, Sharyl J ^a   Davidson, Nancy E ^a,b  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b NONE   (United States)

Author keywords

CpG island methylation; Estrogen receptor (ER); Homozygous deletion; Mutation; Progesterone receptor (PR)

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

BREAST TUMOR; DNA METHYLATION; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MUTATION; REVIEW;

BREAST NEOPLASMS; DNA METHYLATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MUTATION; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE;

EID: 0031597992     PISSN: 10833021     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1018778403001     Document Type: Article

References (68)

1. F. Borellini and T. Oka (1989). Growth control and differentiation in mammary epithelial cells. Environ. Health Perspect 80:85-99.
2. D. L. Ricketts, G. Turnbull, R. Ryall, N. S. B. Bakshi, N. S. B. Raswon, J-C. Gazet, C. Nolan, and R. C. Coombes (1991). Estrogen and progesterone receptor in the normal female breast. Cancer Res. 51:1817-1822.
3. O. W. Peterson, P. E. Hoyer, and B. Van Deurs (1987). Frequency and distribution of estrogen positive cells in normal, non-lactating human breast tissue. Cancer Res. 47:5748-5751.
4. C. Markopoulus, U. Berger, P. Wilson, J. Gazet, and R. C. Coombes (1988). Oestrogen receptor content of normal breast cells and breast carcinoma throughout the menstrual cycle. Brit. Med. J. 296:1349-1351.
5. C. W. Daniels, G. B. Silberstein, and P. Strickland (1987). Direct action of 17-beta estradiol on mouse mammary ducts analyzed by sustain release implants and steroid autoradiography. Cancer Res. 47:6052-6057.
6. G. B. Silberstein, K. Van Horn, G. Shyamala, and C. W. Daniels (1994). Essential role of endogenous estrogen in directly stimulating mammary growth demonstrated by implants containing pure anti-estrogens. Endocrinology 134:84-90.
7. K. S. Korach (1994). Insights from the study of animals lacking functional estrogen receptor. Science 266:1524-1527.
8. J. P. Lydon, F. J. DeMayo, C. R. Funk, S. K. Mani, A. R. Hughes, C. A. Montgomery, Jr., G. Shyamala, O. M. Conneely, and B. W. O' Malley (1995). Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities. Genes Dev. 9:2266-2278.
9. J. P. Lydon, F. J. DeMayo, O. M. Conneely, and B. W. O' Malley (1996). Reproductive phenotypes of the progesterone receptor null mutant mouse. J. Steroid Biochem. Mol. Biol. 56:67-77.
10. H. Gronemeyer (1991). Transcription activation by estrogen and progesterone receptors. Ann. Rev. Genet. 25:89-123.
11. L. Tora, J. White, C. Brou, D. Tasset, N. Webster, E. Scheer, and P. Chambon (1989). The human estrogen receptor has two independent nonacidic transcriptional activation functions. Cell 59:477-487.
12. S. Adler, M. L. Waterman, and M. G. Rosenfeld (1988). Steroid receptor-mediated inhibition of rat prolactin gene expression does not require the receptor DNA-binding domain. Cell 52:685-695.
13. M. Montano, V. Muller, A. Trobaugh, and B. S. Katzenellenbogen (1995). The carboxy-terminal F domain of the human estrogen receptor: role in the transcriptional activity of the receptor and the effectiveness of antiestrogens as estrogen antagonists. Mol. Endocrinol 9:814-825.
14. B. A. Lieberman (1997). The estrogen receptor activity: dependence on multiple protein-protein interactions. Crit. Rev. Euk. Gene Exp. 7:43-59.
15. W. L. Kraus, E. M. McInerney, and B. S. Katzenellenbogen (1995). Ligand-dependent, transcriptionally productive association of the amino-and carboxyl-terminal regions of a steroid hormone nuclear receptor. Proc. Natl. Acad. Sci. USA 92:12314-12318.
16. L. D. Read, C. E. Snider, J. S. Miller, G. L. Greene, and B. S. Katzenellenbogen (1988). Ligand-modulated regulation of progesterone receptor messenger ribonucleic acid and protein inhuman breast cancer cell lines. Mol. Endocrinol. 2:263-271.
17. S. B. Jakowlew, R. Breathnach, J. M. Teltsa, P. Masaikowski, and P. Chambon (1984). Sequence of pS2 mRNA induced by estrogen in the human breast cancer cell line, MCF-7. Nucleic Acids Res. 12:2861-2878.
18. D. Dubik and R. P. C. Shiu (1988). Transcriptional regulation of c-myc oncogene expression by estrogen in hormone-responsive human breast cancer cells. J. Biol. Chem. 263:12705-12708.
19. S. E. Bates, N. E. Davidson, E. M. Valverius, C. E. Freter, R. B. Dickson, J. P. Tam, J. E. Kudlow, M. E. Lippman, and D. S. Salomon (1988). Expression of transforming growth factor and its messenger ribonucleic acid in human breast cancer: its regulation by estrogen and its possible functional significance. Mol. Endocrinol. 2:543-555.
20. A. Bailly, C. Le Page, M. Rauch, and E. Milgrom (1986). Sequence specific DNA binding of progesterone receptor to the uteroglobin gene. EMBO J. 5:3235-3241.
21. V. Lamian, B. Y. Gonzalez, F. J. Michel, and R. C. M. Simmen (1993). Non-consensus progesterone response elements mediate the progesterone-regulated endometrial expression of the uteroferrin gene. J. Steroid Biochem. Mol. Biol. 46:439-450.
22. J. G. Gao, J. Mazella, D. R. Powell, and L. Tseng (1994). Identification of a distal regulatory sequence of the human IGFBP-1 gene promoter and regulation by progesterone receptor in a human endometrial adenocarcinoma cell line. DNA Cell Biol. 13:829-837.
23. W. L. McGuire (1978). Hormone receptors: their role in predicting prognosis and response to endocrine therapy. Seminar Oncol. 5:428-433.
24. G. L. Greene, P. Hilna, M. Waterfield, A. Baker, Y. Hort, and J. Shine (1986). Sequence and expression of human estrogen receptor complementary DNA. Science 231:1150-1154.
25. S. Green, P. Walter, V. Kumar, A. Krust, P-M. Bornet, P. Argos, and P. Chambon (1986). Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A. Nature 320:134-139.
26. M. Ponglikitmonkol, S. Green, and P. Chambon (1988). Genomic organization of the human oestrogen receptor gene. EMBO J. 7:3385-3388.
27. H. Fujii, C. Marsh, P. Cairns, D. Sidransky, and E. Gabrielson (1996). Genetic divergence in the clonal evolution of breast cancer. Cancer Res. 56:1493-1497.
28. H. Iwase, J. M. Greenman, D. M. Barnes, L. Bobrow, S. Hodgson, and C. G. Mathew (1995). Loss of heterozygosity of the oestrogen receptor gene in breast cancer. Brit. J. Cancer 71:448-450.
29. C. K. Watts, M. L. Handel, R. J. B. King, and R. L. Sutherland (1992). Oestrogen receptor gene structure and function in breast cancer. J. Steroid Biochem. Mol. Biol. 41:3-9.
30. S. M. Hill, S. A. W. Fuqua, G. C. Chamness, G. L. Greene, and W. L. McGuire (1989). Estrogen receptor expression in human breast cancer associated with an estrogen receptor gene restriction fragment length polymorphism. Cancer Res. 49:145-148.
31. F. F. Parl, D. R. Cavener, and W. D. Dupont (1989). Genomic DNA analysis of the estrogen receptor gene in breast cancer. Breast Cancer Res. Treat. 14:57-64.
32. L. Yaich, W. D. Dupont, D. R. Cavener, and F. F. Parl (1992). Analysis of the PvuII restriction fragment polymorphism and exon structure of the estrogen receptor gene in breast cancer and peripheral blood. Cancer Res. 52:77-83.
33. N. Roodi, L. R. Bailey, W-Y. Kao, C. S. Verrier, C. J. Yee, W. D. Dupont, and F. F. Parl (1995). Estrogen receptor gene analysis in estrogen receptor-positive and receptor-negative primary breast cancer. J. Natl. Cancer Inst. 87:446-451.
34. T. M. Garcia, T. M. Sanchez, J. L. Cox, P. A. Shaw, J. B. Ross, S. Lehre, and B. Schachter (1989). Identification of a variant form of the human estrogen receptor with an amino acid replacement. Nucleic Acid Res. 17:8364.
35. Q.-X. Zhang, A. Borg, D. M. Wolf, S. Oesterreich, and S. A. W. Fuqua (1997). An estrogen receptor mutant wiath strong hormone-independ ent activity from a metastatic breast cancer. Cancer Res. 57:1244-1249.
36. P. S. Karnik, S. Kulkarni, X-P. Liu, G. T. Budd, and R. M. Bukowski (1994). Estrogen receptor mutation in tamoxifen-resistant cancer. Cancer Res. 54:349-353.
37. D. M. Wolf and V. C. Jordan (1994) The estrogen receptor from a tamoxifen stimulated MCF-7 tumor variant contains a point mutation in the ligand binding domain. Breast Cancer Res. Treat. 31:129-138.
38. W. L. McGuire, G. C. Chamness, and S. A. W. Fuqua (1992). Estrogen receptor variants in clinical breast cancer. Mol. Endocrinol. 5:1571-1577.
39. M. L. Graham, N. L. Kreet, L. A. Miller, K. K. Leslie, D. F. Gordon, W. M. Wood, L. L. Wei, and K. B. Horwitz (1990). T47Dco cells, genetically unstable and containing estrogen receptor mutations, are a model for the progression of breast cancer hormone resistance. Cancer Res. 50:6208-6217.
40. J. J. Pink, S. Y. Jiang, M. Fritsch, and V. C. Jordan (1995). A unique MCF-7 human breast cancer cell line expressing an 80 kD estrogen receptor. Proc. Am. Assoc. Cancer Res. 35:276.
41. Y. L. Ottaviano, J-P. Issa, F. F. Parl, H. S. Smith, S. B. Baylin, and N. E. Davidson (1994). Methylation of the estrogen receptor gene CpG island marks loss of estrogen receptor expression in human breast cancer cells. Cancer Res. 54:2552-2555.
42. R. J. Weigel and E. C. deConinck (1993). Transcriptional control of estrogen receptor in estrogen receptor negative breast carcinoma. Cancer Res. 53:3472-3474.
43. C. Carmeci, E. C. deConinck, T. Lawton, D. A. Bloch, and R. J. Weigel (1997). Analysis of estrogen receptor messenger RNA in breast carcinomas from archival specimens is predictive of tumor biology. Am. J. Pathol. 150:1563-1570.
44. E. C. deConinck, L. A. McPherson, and R. J. Weigel (1995). Transcriptional control of estrogen receptor in breast carcinomas. Mol. Cell. Biol. 15:2191-2196.
45. L. A. McPherson, V. R. Baichwal, and R. J. Weigel (1997). Identification of ERF-1 as a member of the AP2 transcription factor family. Proc. Natl. Acad. Sci. USA 94:4342-4347.
46. A. P. Bird (1986). CpG-rich islands and the function of DNA methylation. Nature 321:209-213.
47. E. Li, C. Beard, and R. Jaenisch (1993). Role of DNA methylation in genomic imprinting. Nature 366:362-365.
48. T. Mohandas, R. S. Sparkes, and L. J. Shapiro (1981). Reactivation of an inactive human X chromosome: evidence for X inactivation by DNA methylation. Science 211:393-396.
49. H. Cedar (1988). DNA methylation and gene activity. Cell 53:3.
50. P. W. Laird and R. Jainisch (1996). The role of DNA methylation in cancer genetics and epigenetics. Ann. Rev. Genet. 30:441-464.
51. J. G. Herman, F. Latif, Y. Weng, M. I. Lerman, B. Zbar, S. Liu, D. Samid, D. S. Duan, J. R. Gnarra, W. M. Linehan, and S. B. Baylin (1994). Silencing of the VHL-tumor suppressor gene by DNA methylation in renal carcinoma. Proc. Natl. Acad. Sci. USA 91:9700-9704.
52. J. G. Herman, A. Merlo, L. Mao, R. G. Lapidus, J-P. Issa, N. E. Davidson, D. Sidransky, and S. B. Baylin (1995). Inactivation of the CDKN2/p16/MST1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res. 55:4525-4530.
53. INK4B1. Cancer Res. 56:722-727.
54. W. H. Lee, R. A. Morton, J. I. Epstein, J. D. Brooks, P. A. Campbell, G. S. Bova, W. S. Hsieh, W. B. Isaacs, and W. G. Nelson (1994). Cytidine methylation of regulatory sequences near the pi-class glutathione S-transferase gene accompanies human prostatic carcinogenesis. Proc. Natl. Acad. Sci. USA 91:11733-11737.
55. J. G. Graff, J. G. Herman, R. G. Lapidus, H. E. Chopra, R. Xu, D. F. Jarrard, W. B. Isaacs, P. M. Pitha, N. E. Davidson, and S. B. Baylin (1995). E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinoma. Cancer Res. 55:5195-5199.
56. R. Piva, A. P. Rimondi, S. Hanau, I. Maestri, A. Alvisi, V. L. Kumar, and L. del Senno (1990). Different methylation of oestrogen receptor DNA in human breast carcinomas with and without oestrogen receptor. Brit. J. Cancer 61:270-275.
57. N. S. Falette, S. A. W. Fuqua, G. C. Chamness, M. S. Cheah, G. L. Greene, and W. L. McGuire (1990). Estrogen receptor gene methylation in human breast tumors. Cancer Res. 50:3974-3978.
58. A. T. Ferguson, R. G. Lapidus, S. B. Baylin, and N. E. Davidson (1995). Demethylation of the estrogen receptor gene in estrogen receptor-negative breast cancer cells can reactivate estrogen receptor gene expression. Cancer Res. 55:2279-2283.
59. R. G. Lapidus, A. T. Ferguson, Y. L. Ottaviano, F. F. Parl, H. S. Smith, S. A. Weitzman, S. B. Baylin, J-P. J. Issa, and N. E. Davidson (1996). Methylation of estrogen and progesterone receptor genes 5′ CpG islands correlates with lack of ER and PR gene expression in breast tumors. Clinical Cancer Res. 2:805-810.
60. M. F. Rousseau-Merck, M. Misrahi, E. Loosfelt, E. Milgrom, and R. von Beger (1987). Localization of the human progesterone receptor gene to chromosome 11q22q23. Human Genet. 77:280-282.
61. I. P. Tomlinson, H. Nicolai, E. Solomon, and W. F. Bodmer (1996). The frequency and mechanism of loss of heterozygosity on chromosome 11q in breast cancer. J. Pathol. 180:38-43.
62. R. Winqvist, G. M. Hampton, A. Mannermaa, G. Blanco, M. Alavaikko, H. Kiviniemi, P. J. Taskinen, G. A. Evans, F. A. Wright, I. Newsham, and W. K. Cavenee (1995). Loss of heterozygosity for chromosome 11 in primary human breast tumors is associated with poor survival after metastases. Cancer Res. 55:2660-2664.
63. S. A. W. Fuqua, S. M. Hill, G. Chamness, M. G. Benedix, G. L. Greene, B. W. O'Malley, and W. L. McGuire (1991). Progesterone receptor gene restriction fragment length polymorphism in human breast tumors. J. Natl. Cancer Inst. 83:1157-1160.
64. T. P. Manolitsas, P. Englefield, D. M. Eccles, and I. G. Campbell (1997). No association of a 306-bp insertion polymorphism in the progesterone receptor gene with ovarian and breast cancer. Brit. J. Cancer 75:1398-1399.
65. K. L. Satya-Prakash, S. Pathak, T. C. Hsu, M. Olive, and R. Cailleau (1981). Cytogenetic analysis on eight human breast tumor cell lines: high frequencies of 1q, 11q and HeLa-like marker chromosome. Cancer Genet. Cytogenet. 3:61-73.
66. C. Mies and W. Voigt (1996). Sequence analysis of the DNA binding domain of the estrogen receptor gene in ER(+)/PR(-) breast cancer. Diagnostic Mol. Pathol. 5:39-44.
67. L. Kastner, A. Krust, B. Turcotte, U. Stropp, L. Tora, H. Gronemeyer, and P. Chambon (1990). Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B. EMBO J. 9:1603-1614.
68. M. Misrahi, P. Venecie, P. Saugier-Veber, S. Sars, P. Dessen, and E. Milgrom (1993). Structure of the human progesterone receptor gene. Biochim. Biophys Acta 1216:289-292.